Aspen targeting Mounjaro expansion will bring the high-demand drug Mounjaro to Sub-Saharan Africa. Mounjaro is also known as tirzepatide. Launches across the continent are anticipated in 2026. CEO Stephen Saad confirmed this plan. He announced it in his annual letter to shareholders. The move follows major success in South Africa. It also comes after a new regulatory approval. This approval…